OGG1 and juvenile Huntington disease: Inhibition of OGG1 to prevent somatic trinucleotide repeat expansion in Huntington’s disease also has high priority due to the extreme morbidity and mortality of the condition and the lack of other drugs, although lead compounds capable of brain delivery have not been reported so far.